Scientists have discovered a new antibiotic, teixobactin, that can kill serious infections in mice without encountering any detectable resistance, offering a potential new way to get ahead of dangerous evolving superbugs.
Researchers said the antibiotic, which has yet to be trialled in humans, could one day be used to treat drug-resistant infections caused by the superbug MSRA, as well as tuberculosis, which normally requires a combination of drugs that can have adverse side effects.
“The discovery of this novel compound challenges long-held scientific beliefs and holds great promise for treating an array of menacing infections,” said Kim Lewis, a professor at Northeastern University in the United States and co-founder of the NovoBiotic Pharmaceuticals, which has patented teixobactin.
more http://www.reuters.com/article/2015/01/08/us-health-antibiotic-discovery-idUSKBN0KH10S20150108